Verada Rehab Clinics
Someone has to go first.
Rehabilitation technology that works abroad does not fail in the UK on the science. It fails because no clinic will buy what no clinic has run, and no commissioner will fund what has never been costed here. We break that loop by going first, at our own commercial risk, and publishing what we find.
Technologies enter at the stage they are actually at
The evidence you can collect depends entirely on where a technology sits, and some of it cannot be collected later at any price. There is no single entry point, and no requirement to choose only one.
Approval is where the hard part starts
A CE or FDA mark says a technology is safe and performs as intended. It says nothing a clinic director actually needs to know before committing capital and clinical time.
- How many sessions a week can one device realistically deliver?
- What grade of therapist is required, and how long does training take?
- Will it be used, or will it sit in a cupboard by month four?
- What does a session cost to deliver, and what does it earn?
- How long until the investment pays back?
- What happens if the trained therapist leaves?
A manufacturer cannot generate it, because they do not run clinics. A registry cannot, because it collects outcomes rather than operations. An academic centre cannot credibly, because its cost base and staffing do not resemble a commercial clinic's. That leaves a gap that only a real service, run at real cost, can fill.
Deliver the care. Publish the proof.
We adopt technology already proven in other health systems and put it in front of UK patients, under qualified clinical supervision, before anyone else is willing to. Everything else follows from doing that one thing properly.
Treat patients
Structured, protocolised rehabilitation for neurological, musculoskeletal and cognitive conditions, delivered by trained clinicians against defined selection criteria. This is the service, and it is what patients pay for.
Instrument everything
Repetitions, intensity against each patient's own calibrated maximum, session duration, adherence, pre- and post-session symptom ratings. Recorded as a by-product of care rather than as a separate research burden.
Publish what it costs
Utilisation, throughput, therapist grade, training time, completion and dropout, cost and revenue per session, payback period. The numbers a clinic director needs and nobody currently publishes.
Not all evidence answers the same question
"Real-world evidence" is usually taken to mean clinical outcomes. That is one third of what a technology needs to reach scale, and it is the third that is already best served.
Two relationships, one service
Access to treatment that exists, but not here yet
Technology routinely available in other health systems, delivered under qualified clinical supervision, with honest information about who it suits and who it does not.
- Clear eligibility assessed before you commit, not after
- Realistic expectations: ranges rather than promises
- Structured programmes with progress measured objectively each session
- Qualified clinicians working to defined protocols
You have the mark. You don't have UK scale.
We become your first UK site at our own commercial risk, and turn going first into a package that lets the clinics after us go second.
- A named reference site treating real patients under a registered provider
- Operational proof: utilisation, throughput, therapist grade, training time, dropout
- Economic proof: cost and revenue per session, payback period, budget impact
- A deployment blueprint: protocols, selection criteria, SOPs, training curriculum
- Clinicians who take a peer's phone call and say what it was actually like
We publish the numbers we would rather not
The whole proposition rests on being a credible reference. A site that only ever reports flattering figures is a marketing exercise, and buyers work that out quickly.
The same principle applies to outcomes. Where a technology does not deliver what was expected in our population, we say so, including for technologies we hold commercial relationships with. Independence that has never cost anything is not independence.
Honest status
What sits alongside
The clinic is the asset the rest of Verada runs on. The same trained staff, the same instrumentation and the same data layer serve two further functions.
Bring us a technology
If you manufacture rehabilitation technology that works elsewhere and stalls in the UK, or you are a clinician who wants to refer, we would like to hear from you.
Start a conversation →